Management of gram-positive bacterial infections in patients with cancer
- 24 August 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 53 (1), 8-18
- https://doi.org/10.3109/10428194.2011.602770
Abstract
Bacterial infections, particularly those due to gram-positive bacteria, continue to predominate in patients with cancer. Coagulase-negative and coagulase-positive staphylococci and enterococci remain as common pathogenic microorganisms. Clostridium difficile has emerged as a significant pathogen. Major clinical syndromes include vascular catheter-related infection, febrile neutropenia, diarrhea and colitis. Rising antimicrobial resistance among gram-positive bacteria is of serious concern. The clinical utility of penicillin against streptococci and vancomycin against coagulase-negative and coagulase-positive staphylococci and enterococci may be rapidly diminishing. Liberal empiric use of vancomycin during neutropenic fever needs careful reconsideration. Newer promising anti-gram-positive bacterial drugs with activity against methicillin-resistant staphylococci include daptomycin, linezolid, tigecycline and telavancin. However, toxicity concerns, limited data in immunocompromised populations and high cost prevent the widespread use of these drugs among patients with cancer.Keywords
This publication has 69 references indexed in Scilit:
- Factors associated with mortality in bacteremic patients with hematologic malignanciesDiagnostic Microbiology and Infectious Disease, 2009
- The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patientsInternational Journal of Infectious Diseases, 2006
- Current Spectrum of Bacterial Infections in Patients with CancerClinical Infectious Diseases, 2003
- Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United StatesClinical Infectious Diseases, 2003
- Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisThe Hematology Journal, 2003
- Management of infection in cancer patients: studies of the EORTC International Antimicrobial Therapy Group (IATG)European Journal of Cancer, 2002
- Aerobic bacterial and fungal infections in peripheral blood stem cell transplantsBone Marrow Transplantation, 2001
- Microbiological Findings in Febrile NeutropeniaArchives of Medical Research, 2000
- Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical TrialsClinical Infectious Diseases, 1997
- Predominance of Gram-Positive Microorganisms as a Cause of Septicemia in Patients with Hematological MalignanciesInfection Control & Hospital Epidemiology, 1994